ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1344	National Cancer Institute	Html	en	How To Handle Withdrawal Symptoms and Triggers When You Decide To Quit Smoking	This fact sheet provides helpful tips related to smoking cessation.	routine smoke breaks 0.282965 smoking effects 0.278771 relaxation techniques 0.313407 nicotine addiction 0.355656 Control Research Branch 0.30123 Yes. Nicotine replacement 0.344131 nicotine withdrawal symptoms 0.36823 urge 0.354906 tips 0.337093 negative feelings 0.295635 Nicotine nasal spray 0.380205 tea 0.279209 Tobacco Control Research 0.298555 things 0.265705 tobacco smoke 0.262113 nicotine replacement therapy 0.347084 drinking coffee 0.292775 highly dependent smokers 0.261935 daily life 0.289451 Smoking Quitline 0.271985 Step-by-Step Quit Guide 0.333256 nicotine replacement products 0.922705 help quitting tobacco 0.287795 nicotine replacement product 0.346885 smoking increase 0.274802	weight gain 0.385772 smokers 0.365077 counter weight gain 0.289631 nicotine cravings 0.53551 nicotine doses 0.315612 common negative feelings 0.293918 smoking 0.59993 nicotine lozenge 0.318321 nicotine inhaler 0.328106 nicotine travels 0.313333 nicotine level drops 0.347286 chews nicotine gum 0.341989 people 0.407906 strong urge 0.298124 physical activity 0.320031 people smoking 0.295038 nicotine gum 0.386182 nicotine patch 0.339006 withdrawal symptoms 0.655994 common withdrawal symptoms 0.360181 coffee 0.312007 smoking cessation trials 0.292819 Occasional mild cravings 0.284899 time 0.303672	CLICK HERE
1420	National Cancer Institute	Html	en	Prostate Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing prostate cancer and about research aimed at the prevention of this disease.	hereditary prostate cancer 0.542395 prostate biopsy 0.533126 dutasteride group vs 0.459041 skin cancer 0.446356 prostate cancer period 0.528407 cancer mortality rates 0.459369 prostate volume subgroups 0.508967 Prostate Cancer Events 0.558338 finasteride group versus 0.448086 rat ventral prostate 0.516053 high-grade tumors 0.479135 high-grade cancer 0.454168 prostate cancer-specific mortality 0.525559 occult prostate cancer 0.561891 high-grade prostate cancer 0.548137 prostate preventive effects 0.507979 relative risk reduction 0.446967 radical prostatectomy 0.460894 prostate cancer mortality 0.534065 prostate cancer chemoprevention 0.531007 dietary fat 0.445789 men 0.4492 Cancer Events trial 0.451937 negative prostate biopsy 0.515564	digital rectal examination 0.454846 dutasteride group 0.460003 fat intake 0.450377 Cancer Prevention Trial 0.500983 prostate digital 0.500034 prostate cancer risk 0.564597 placebo group 0.469544 incident prostate cancer 0.532469 Cancer Events study 0.447937 prostate volume 0.517049 absolute risk reduction 0.495169 low biologic risk 0.447169 finasteride group 0.448145 prostate cancer 0.910772 Gleason 0.458954 clinical prostate cancer 0.556069 pancake-appearing prostate 0.508749 Prostate Cancer Prevention 0.595277 prostate cancer. 0.505972 prostate cancer death. 0.562581 statistically significant difference 0.470146 prostate cancers 0.559985 human prostate cancer 0.538634	CLICK HERE
1495	National Cancer Institute	Html	en	Hairy Cell Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of hairy cell leukemia.	purine analog therapy 0.544174 BRAF inhibitor 0.537215 overall response rate 0.600065 cell leukemia patients 0.629349 purine analogs 0.574118 Hot Flashes 0.53761 complete remission rate 0.547966 long-term follow-up 0.53699 long term follow-up 0.54098 Tiacci et al. 0.545702 Foucar MK 0.540256 classic-form hairy cell 0.592078 cell leukemia variants. 0.563299 peripheral blood counts 0.541349 Pettirossi et al. 0.546064 median overall survival 0.57455 9-year median follow-ups 0.545986 patients 0.634056 continuous infusion 0.540582 multicenter studies 0.537514 VH4-34+ hairy cell 0.567746 B-cell lymphomas 0.539052 Rosenberg et al. 0.545728 Natl Cancer Inst 0.537773	hairy-cell leukemia 0.564359 Night Sweats 0.538245 et al. 0.547621 median treatment-free survival 0.574134 partial remission rate 0.543701 stable partial remission 0.545722 cladribine 0.537399 complete remissions 0.537086 one-time continuous infusion 0.53916 comparable response rates 0.548208 treatment option 0.539331 median follow-up 0.54766 potential increased risk 0.575127 cell leukemia variant 0.57205 overall response rate. 0.539597 complete response rate 0.636139 Abstract 0.548918 hairy cell leukemia 0.918712 Clin Oncol 0.592807 subcutaneous injections 0.544059 PDQ summary 0.53807 cell leukemia variants 0.563543 previously untreated patients 0.548389 standardized incidence ratio 0.536889	CLICK HERE
1618	National Cancer Institute	Html	en	Late Effects of Treatment for Childhood Cancer (PDQ®)–Patient Version	The treatment of cancer may cause health problems (late effects) for childhood cancer survivors months or years after successful treatment has ended. Get information about the long-term physical, psychological and social effects of treatment for childhood cancer in this expert-reviewed summary.	childhood cancers 0.431043 cancer treatment 0.371211 body 0.373967 childhood cancer survivors 0.770496 chemotherapy 0.372336 PDQ cancer information 0.35879 total-body irradiation 0.354372 ovarian late effects 0.364333 bile duct 0.348106 talk 0.386582 chest radiation treatment 0.353115 kidney late effects 0.373747 joint late effects 0.365129 cancer information summary 0.349224 stem cell transplant 0.480939 pancreatic late effects 0.367016 heart 0.364096 symptoms 0.373794 health problems 0.529948 tests 0.430651 primary cancer diagnosis 0.352818 radiation therapy 0.438948 following 0.347799 hormone replacement therapy 0.348511	late effects 0.94258 treatment 0.571093 blood vessel 0.385075 primary cancer 0.359907 signs 0.42599 related health problems 0.511763 procedures 0.374731 National Cancer Institute 0.350345 spinal cord 0.453656 disease 0.351393 breast cancer risk 0.350432 breast cancer 0.372761 brain tumor 0.349819 thyroid late effects 0.395111 brain 0.380353 doctor 0.354325 radiation treatment 0.379126 radiation 0.476283 acute lymphoblastic leukemia 0.349699 health habits 0.363956 neuroendocrine late effects 0.359016 high blood pressure 0.347712 nonmelanoma skin cancer 0.356812 lung late effects 0.390136	CLICK HERE
1649	National Cancer Institute	Html	en	Aromatherapy and Essential Oils (PDQ®)–Patient Version	Expert-reviewed information summary about the use of aromatherapy and essential oils to improve the quality of life of cancer patients.	PDQ Aromatherapy 0.51751 cancer treatment 0.518478 modern aromatherapy 0.502296 certain essential oils 0.545828 aromatherapy training 0.496531 PDQ cancer information 0.582174 Cancer Complementary 0.49782 hormone -like effects 0.496783 clinical trials 0.646919 cancer information summary 0.54045 aromatherapy massage 0.496545 alternative cancer therapies 0.488792 clinical trial 0.515897 CAM cancer research 0.479249 patients 0.520207 cancer patients 0.499565 Aromatherapy products 0.529674 bergamot essential oil 0.494855 literature discuss aromatherapy 0.518185 NCI PDQ cancer 0.50787 cancer information database 0.486869 aromatherapy 0.710126 international aromatherapy programs 0.515466 Therapies Editorial Board 0.490712	essential oils 0.964677 cancer information 0.591001 treatment 0.540034 Complementary Therapies Editorial 0.514222 Drug Administration 0.547203 Cancer Information Specialist 0.481775 Aromatherapy research 0.515581 tree essential oils 0.64448 Cancer Information Service 0.537651 tree essential oil 0.496279 Antibacterial essential oils 0.531896 National Cancer Institute 0.639762 alternative medicine 0.561892 standard aromatherapy certification 0.518782 term aromatherapy 0.502247 orange essential oil 0.494346 aromatherapy courses 0.496618 tea tree 0.549957 cancer clinical trials 0.48888 alternative therapies 0.505894 ginger essential oil 0.493305 cancer information summaries 0.487611 cancer 0.667969 Holistic Aromatherapy 0.506338	CLICK HERE
1661	National Cancer Institute	Html	en	Antineoplastons (PDQ®)–Health Professional Version	Expert-reviewed information summary about antineoplastons as a treatment for people with cancer.	various tumor suppressor 0.673325 high-risk pediatric patients 0.613742 cell lines 0.732784 antineoplaston A10. 0.614589 steady state concentration 0.632482 mean steady state 0.62987 stable disease 0.629423 tumor suppressor genes 0.670419 antineoplaston a10 0.785651 multiple brain metastases 0.666381 clinical trials 0.642258 cancer cell line 0.621623 cancer information summary 0.628466 highest tumor response 0.628298 patients 0.960903 cancer patients 0.782838 average dose 0.662612 human colon cancer 0.66679 tumor progression 0.629611 colon cancer cells 0.664834 antineoplaston treatment 0.679278 complete tumor response 0.726436 metastatic brain tumor 0.711993 study 0.663173 neutrophil apoptosis 0.623745	Human/Clinical Studies section 0.637915 neoplastic cell lines 0.689948 human blood 0.654645 cancer cells 0.75191 animal tumor systems 0.612469 National Cancer Institute 0.656232 tumor growth 0.643714 breast cancer patients 0.772855 partial tumor response 0.663127 AS2-1 0.676129 antineoplaston therapy 0.747438 white blood cell 0.631532 antineoplaston A. 0.675544 abnormal cells 0.630356 human tumor tissue. 0.623365 human urine 0.617971 antineoplastons 0.86378 experimental cancer therapy 0.633011 chronic lymphocytic leukemia 0.610232 tumor response 0.767878 objective tumor response 0.612044 naturally occurring biochemical 0.637098 antineoplastons A10 0.665762 cancer 0.805413	CLICK HERE
2015	National Cancer Institute	Html	es	Prevención del cáncer de pulmón (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que influirían en el riesgo de presentar cáncer de pulmón y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	cigarrillo encendido 0.533546 voluntarios sanos 0.521783 secciones llamadas lóbulos 0.564444 factor protector 0.54356 rayos x 0.525531 rayos gamma 0.526755 altas cantidades 0.523911 vías respiratorias 0.534485 suplementos vitamina 0.527073 membrana delgada llamada 0.563077 National Cancer Institute 0.526876 Más personas 0.538369 Instituto Nacional 0.548081	antecedentes familiares 0.770813 siguientes factores 0.598507 Physician Data Query 0.601335 gas radón 0.544843 prevención revisa 0.523285 PDQ Prevención 0.542908 siguientes sustancias 0.533013 Menor exposición 0.544963 órganos respiratorios 0.535883 principal causa 0.53309 factores protectores 0.947087 siguientes sumarios 0.567797 suplementos alimenticios 0.525893	CLICK HERE
2029	National Cancer Institute	Html	es	Prevención del cáncer de seno (mama) (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer de mama y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	Sestak I 0.314213 Methods Mol Biol 0.309681 menor incidencia 0.315649 Breast Cancer Surveillance 0.32247 largo plazo 0.325123 Risk Calculator 0.330192 Cuzick J 0.314017 breast cancer prevention 0.340448 útero intacto 0.328063 Estados Unidos 0.337849 menor riesgo 0.381674 cancer prevention trial 0.330827 Women's Health Initiative 0.311811 principal factor 0.31767 Health Initiative 0.316067 from benign breast 0.320129 Breast density 0.313434 lobular breast 0.315708 English record linkage 0.310983 hormonas estrógeno 0.31642 health study 0.316005 benign breast 0.353338 Cancer Res Treat 0.315355 Cancer Risk Assessment 0.316082 Epidemiol Biomarkers Prev 0.309854	enfermedad proliferativa benigna 0.311069 Goss PE 0.314786 antecedentes familiares 0.49279 Breast Risk Calculator 0.318395 prospective cohort study 0.311422 breast cancer risk 0.370651 reducción promedio 0.315263 breast cancer 0.951386 cardiopatía coronaria 0.328283 riesgos instantáneos 0.314306 IBIS-I breast 0.313331 risk factor 0.343815 mujeres portadoras 0.329041 Cancer Surveillance System 0.312955 IBIS Breast Cancer 0.320333 heritable risk factor 0.311842 Risk Calculator Tool 0.311 Reino Unido 0.311996 Women’s Health Initiative 0.309787 Breast Cancer Referral 0.321555 parenchymal patterns as 0.309616 Otro estudio 0.316688 Breast Cancer Res 0.357313 mujeres jóvenes 0.346647	CLICK HERE
2037	National Cancer Institute	Html	es	Prevención del cáncer de piel (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de piel y sobre las investigaciones dirigidas a prevenir esta enfermedad.	skin cancer 0.991265 cutaneous melanoma 0.469757 Lippincott Williams 0.41932 skin cancer prevention 0.612003 prevent skin 0.440602 protectores solares 0.469609 Williams GM 0.418343 queratosis solares 0.585992 Sin embargo 0.685934 protector solar 0.843096 American Cancer Society 0.553421 Prev Med 0.458565 cancer prevention study 0.448174 case-control study 0.424296 Study Group 0.427125 DeVita VT Jr 0.43478 risk factors 0.435855 with nonmelanoma skin 0.42056 isotretinoin-basal cell carcinomas 0.418488 randomized trial 0.462527 exposición solar 0.710997 Natl Cancer Inst 0.487884 8th ed 0.41947 protección solar 0.624745 melanoma risk factors 0.418328	pruebas insuficientes 0.419855 Nambour Skin Cancer 0.466485 cell carcinomas 0.512878 Halliday GM 0.422507 Arch Dermatol 0.425176 Wilson LD 0.417928 Cancer Facts 0.43005 Aasi SZ 0.421096 nevos melanocíticos benignos 0.418665 protector solar ayuda 0.422241 controlled trial 0.45893 protector solar versus 0.425736 Epidemiol Biomarkers Prev 0.463973 exposición solar aguda 0.467654 Cancer Prevention Trial 0.454925 Thomas VD 0.418204 Reduce Actinic Cancer 0.419285 radiación uv 0.425436 randomized controlled trial 0.440826 radiación solar 0.432514 crema base 0.420169 nonmelanoma skin cancer 0.715174 radiación ultravioleta 0.572893 Cancer Study Group 0.420229	CLICK HERE
2069	National Cancer Institute	Html	es	Enfermedad de Paget de seno	Hoja informativa sobre la enfermedad de Paget de seno, un tipo poco común de cáncer que algunas veces se llama enfermedad de Paget del pezón o enfermedad de Paget de mama.	Lippincott Williams 0.227873 Tumor Characteristics 0.23784 Eisner MP 0.227823 cáncer invasor 0.852818 afecciones benignas 0.232299 Cody HS 0.226638 Female Breast 0.245015 posibles tumores 0.243494 long-term follow-up study 0.244429 Breast Cancer Research 0.268606 siglo xix sir 0.249073 breast-conserving therapy 0.228801 Lippman ME 0.226791 ganglios linfáticos centinela 0.294176 afección benigna 0.309089 SEER Program 0.276615 Kanitakis J 0.22651 estadio i 0.22947 Hasson D 0.226314 European Institute 0.226377 Keel GE 0.226988 PubMed Abstract 0.996634 Haffty BG 0.225876 clinical presentation 0.228015 Therapeutic options 0.226841	with radiotherapy 0.228051 Tucker SL 0.226414 Paget mamaria 0.499743 estadio iv 0.228625 End Results 0.22623 Griffith KA 0.226914 signo revelador 0.231703 proteína her2 0.228884 National Cancer Institute 0.247867 4th ed 0.228822 Sosnovskikh I 0.226721 Ries LAG 0.280943 edad promedio 0.227469 Breast Journal 0.241614 Osborne CK 0.226941 Sir James Paget 0.694935 Cancer Survival Among 0.251885 estadio iii 0.228362 Gatti G 0.22751 Retrieved April 0.227819 sentinel lymph 0.278815 European Academy 0.22756 extramammary paget 0.443981 Dimaio DJ 0.226799	CLICK HERE